These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 34780804)

  • 1. Clinical characteristics and symptom duration among outpatients with COVID-19.
    Lane A; Hunter K; Lee EL; Hyman D; Bross P; Alabd A; Betchen M; Terrigno V; Talwar S; Ricketti D; Shenker B; Clyde T; Roberts BW
    Am J Infect Control; 2022 Apr; 50(4):383-389. PubMed ID: 34780804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample.
    Caplan A; Bates KW; Brioni C; Santos A; Sabatini LM; Kaul KL; Carnethon MR; Khandekar JD; Greenland P
    PLoS One; 2021; 16(10):e0258970. PubMed ID: 34673816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
    Mollan KR; Eron JJ; Krajewski TJ; Painter W; Duke ER; Morse CG; Goecker EA; Premkumar L; Wolfe CR; Szewczyk LJ; Alabanza PL; Loftis AJ; Degli-Angeli EJ; Brown AJ; Dragavon JA; Won JJ; Keys J; Hudgens MG; Fang L; Wohl DA; Cohen MS; Baric RS; Coombs RW; Sheahan TP; Fischer WA
    Clin Infect Dis; 2022 Aug; 75(1):e1028-e1036. PubMed ID: 35022711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
    Nasserie T; Hittle M; Goodman SN
    JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
    Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
    JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients affecting the duration of positivity at SARS-CoV-2: a cohort analysis of the first wave of epidemic in Italy.
    Milani L; Cigliano F; Catalano A; Macciotta A; Viola M; Caramello V; Costa G; Ricceri F; Sacerdote C
    Epidemiol Prev; 2021; 45(6):533-542. PubMed ID: 35001598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
    Wang D; Hu B; Hu C; Zhu F; Liu X; Zhang J; Wang B; Xiang H; Cheng Z; Xiong Y; Zhao Y; Li Y; Wang X; Peng Z
    JAMA; 2020 Mar; 323(11):1061-1069. PubMed ID: 32031570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics of Hospital Follow-up for Patients Hospitalized from SARS CoV-2 (COVID 19) in an Academic Outpatient Internal Medicine Clinic.
    Abohelwa M; Peterson CJ; Landis D; Le D; Conde C; DeWare C; Elgendy F; Payne D; Nugent K
    J Prim Care Community Health; 2022; 13():21501319221134560. PubMed ID: 36314373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19.
    Jabr R; Khatri A; Anderson AD; Garcia LC; Viotti JB; Natori Y; Raja M; Camargo JF; Morris MI
    Transpl Infect Dis; 2023 Feb; 25(1):e14006. PubMed ID: 36704987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study.
    Pierce-Williams RAM; Burd J; Felder L; Khoury R; Bernstein PS; Avila K; Penfield CA; Roman AS; DeBolt CA; Stone JL; Bianco A; Kern-Goldberger AR; Hirshberg A; Srinivas SK; Jayakumaran JS; Brandt JS; Anastasio H; Birsner M; O'Brien DS; Sedev HM; Dolin CD; Schnettler WT; Suhag A; Ahluwalia S; Navathe RS; Khalifeh A; Anderson K; Berghella V
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100134. PubMed ID: 32391519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
    Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP
    JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    Naggie S; Boulware DR; Lindsell CJ; Stewart TG; Gentile N; Collins S; McCarthy MW; Jayaweera D; Castro M; Sulkowski M; McTigue K; Thicklin F; Felker GM; Ginde AA; Bramante CT; Slandzicki AJ; Gabriel A; Shah NS; Lenert LA; Dunsmore SE; Adam SJ; DeLong A; Hanna G; Remaly A; Wilder R; Wilson S; Shenkman E; Hernandez AF;
    JAMA; 2022 Oct; 328(16):1595-1603. PubMed ID: 36269852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
    Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
    JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.